4th Quarter - Report

F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES

Firm
Client
Income
—
Expenses
$135,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.160-Protect Medical Innovation Act of 2015 S.149-Medical Device Access and Innovation Protection Act H.R.6-21st Century Cures Act Yet to be introduced House proposal to have the FDA regulate laboratory developed tests Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests H.R. 771-Protecting Access to Diabetes Supplies Act of 2015 Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies

LobbyistCovered position, as disclosed
RUSSELL CONWELL RING VP Government Affairs Roche Diagnostics Diabetes
BRUCE THOMAS TAYLOR Director

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 149 (114th), H.R. 771 (114th), H.R. 6 (114th), H.R. 160 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.